United Kingdom· GB-APID-45734811000001108
Loqtorzi 240mg/6ml concentrate for solution for infusion vials
A toripalimab product containing toripalimab, registered in United Kingdom by LEO Pharma. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Toripalimab is registered in 12 of 19 countries.
Countries holding a registration under ATC L01FF13 (toripalimab), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Toripalimab · ATC L01FF13
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Toripalimab
- Manufacturer
- LEO Pharma
- Country
- United Kingdom (GB)
- ATC code
- L01FF13
- ATC class
- Toripalimab
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin05391549650005
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Toripalimab in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesLOQTORZICoherus Oncology, Inc.
- CzechiaLOQTORZITopalliance Biosciences Europe Limited, Dublin
- SpainLOQTORZI 240 MG CONCENTRADO PARA SOLUCION PARA PERFUSIONTopalliance Biosciences Europe Limited
- FinlandLOQTORZITopalliance Biosciences Europe Limited
- FranceLOQTORZI 240 mg, solution à diluer pour perfusionTOPALLIANCE BIOSCIENCES EUROPE (IRLANDE)
- IrelandLOQTORZI 240 mg concentrate for solution for infusionTopalliance Biosciences Europe Limited
- BelgiumLoqtorzi 240 mgTopalliance Biosciences Europe
- NetherlandsLOQTORZI 240 mg concentraat voor oplossing voor infusieTopalliance Biosciences Europe Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Loqtorzi
- Liechtenstein · Loqtorzi
- Norway · Loqtorzi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/32a8fe42-8861-4bd4-918c-7ba078a4ff66 GET /v1/drugs/32a8fe42-8861-4bd4-918c-7ba078a4ff66?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "45734811000001108",
"desc": "Loqtorzi 240mg/6ml concentrate for solution for infusion vials (LEO Pharma)",
"form": "Solution for infusion",
"vpid": "45801311000001105",
"source": "dmd",
"vtm_id": "45800711000001101",
"strength": "40 mg",
"substance": "Toripalimab",
"ingredient": "Toripalimab",
"supplier_code": "2269001000001104"
}See everything about toripalimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.